Accueil   Diary - News   All news ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2022

ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2022

 

 

 

Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases with innovative formulations of peptides and proteins, today announced its participation at upcoming virtual investor conferences.


Adocia management team members will be available for virtual meetings: Gérard Soula (CEO), Olivier Soula (Deputy General Manager) and Valérie Danaguezian (Chief Financial Officer).

 

 

 

Read the press release